RBO & Co. LLC Boosts Holdings in The Procter & Gamble Company (NYSE:PG)

RBO & Co. LLC boosted its position in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 13.1% during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 1,923 shares of the company’s stock after purchasing an additional 223 shares during the quarter. RBO & Co. LLC’s holdings in Procter & Gamble were worth $333,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of the company. FMR LLC boosted its position in shares of Procter & Gamble by 2.7% during the third quarter. FMR LLC now owns 26,556,319 shares of the company’s stock valued at $4,599,554,000 after buying an additional 689,282 shares during the last quarter. Legal & General Group Plc grew its stake in shares of Procter & Gamble by 0.6% during the 2nd quarter. Legal & General Group Plc now owns 21,632,054 shares of the company’s stock valued at $3,567,556,000 after purchasing an additional 122,190 shares during the period. Fisher Asset Management LLC increased its position in shares of Procter & Gamble by 4.7% during the 3rd quarter. Fisher Asset Management LLC now owns 18,380,610 shares of the company’s stock valued at $3,183,522,000 after purchasing an additional 830,476 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its stake in shares of Procter & Gamble by 0.6% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 16,422,470 shares of the company’s stock worth $2,844,442,000 after purchasing an additional 105,734 shares during the period. Finally, Dimensional Fund Advisors LP grew its position in Procter & Gamble by 8.2% during the second quarter. Dimensional Fund Advisors LP now owns 9,691,925 shares of the company’s stock valued at $1,598,510,000 after buying an additional 733,440 shares during the period. 65.77% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Procter & Gamble

In related news, insider Balaji Purushothaman sold 12,800 shares of the stock in a transaction dated Thursday, November 21st. The shares were sold at an average price of $172.73, for a total value of $2,210,944.00. Following the sale, the insider now directly owns 11,595 shares of the company’s stock, valued at $2,002,804.35. This represents a 52.47 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Jon R. Moeller sold 7,007 shares of the business’s stock in a transaction that occurred on Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total value of $1,202,751.55. Following the transaction, the chief executive officer now owns 269,172 shares of the company’s stock, valued at $46,203,373.80. This trade represents a 2.54 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 35,233 shares of company stock worth $6,024,234. 0.18% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several research analysts have weighed in on PG shares. Wells Fargo & Company increased their price target on shares of Procter & Gamble from $188.00 to $190.00 and gave the stock an “overweight” rating in a research report on Friday, November 22nd. Evercore ISI increased their target price on shares of Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a report on Monday, October 21st. Hsbc Global Res upgraded shares of Procter & Gamble to a “strong-buy” rating in a research report on Friday, October 4th. StockNews.com lowered Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Finally, Royal Bank of Canada restated a “sector perform” rating and issued a $164.00 price objective on shares of Procter & Gamble in a research report on Monday, October 21st. Eight equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $180.45.

Read Our Latest Stock Analysis on PG

Procter & Gamble Stock Up 1.1 %

Shares of NYSE PG opened at $179.31 on Wednesday. The stock has a market capitalization of $422.28 billion, a price-to-earnings ratio of 30.92, a P/E/G ratio of 3.82 and a beta of 0.42. The Procter & Gamble Company has a 12-month low of $142.50 and a 12-month high of $179.46. The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50. The firm’s 50-day moving average price is $170.11 and its 200-day moving average price is $168.83.

Procter & Gamble (NYSE:PGGet Free Report) last posted its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.90 by $0.03. The business had revenue of $21.74 billion during the quarter, compared to analyst estimates of $21.99 billion. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The company’s revenue for the quarter was down .6% on a year-over-year basis. During the same period last year, the company earned $1.83 EPS. On average, equities research analysts anticipate that The Procter & Gamble Company will post 6.96 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were paid a $1.0065 dividend. This represents a $4.03 annualized dividend and a dividend yield of 2.25%. The ex-dividend date of this dividend was Friday, October 18th. Procter & Gamble’s dividend payout ratio is currently 69.48%.

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

See Also

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.